Symptoms
Medicinal cannabis: Patient access and clinical evidence
In the August 2017 edition of Australian Pharmacist (page 10), I provided background on the regulatory scheme for cultivation and manufacture of medicinal cannabis,...
What transpired at the inaugural GP-Pharmacists Symposium?
PSA's inaugural GP Pharmacists Symposium underscored the expanding scope of the profession – and the policy gaps that still need closing.
NDSS changes to assist in diabetes management
Changes to the Australian Government’s National Diabetes Services Scheme (NDSS) took effect on 1 December, altering the range and price of certain products available...
The accidental pharmacist
Cathie Reid MPS is an entrepreneur, a self-confessed ‘tech geek’, a philanthropist and healthcare pioneer. But her career trajectory could have been very different...
Dapagliflozin for infertility for women with obesity
This glucose-lowering diabetes drug may have therapeutic benefits and clinical utility for people with reproductive dysfunction.
Heading off patient harm from medicines
Medicine adherence, deprescribing and establishing systems to prevent error recurrence are all part of the pharmacist’s calling to protect patient safety.
Pharmacists, as custodians of...
